NCT02252913View on ClinicalTrials.gov

A Study of Safety and Pharmacokinetics of Volitinib With Docetaxel in Patients With Advanced Gastric Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Gastric Cancer
Interventions
DRUG

Volitinib

oral administration

DRUG

Docetaxel

intravenous injection

Trial Locations (1)

200032

Fudan University Shanghai Cancer Hospital, Shanghai

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Hutchison Medipharma Limited

INDUSTRY